Immunology Market – Trends Forecast Till 2030

1
Immunology Market Trends Forecast Till 2030
sales_at_delvens.com www.delvens.com
2
Immunology Market- Trends Forecast Till 2030
Immunology Market, by Drug Class (Monoclonal
Antibody (mAb), Fusion Proteins,
Immunosuppressants, Polyclonal Antibody (pAb),
and Others), by Disease Indication (Rheumatoid
Arthritis, Psoriatic Arthritis, Plaque Psoriasis,
Ankylosing Spondylitis, Inflammatory Bowel
Disease, Prophylaxis of Organ Rejection, and
Others), by Distribution Channel (Hospital
Pharmacies, Retail Pharmacies, and Online
Pharmacies) and region (North America, Europe,
Asia-Pacific, Middle East and Africa and South
America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/immunology
-market-trends-forecast-till-2030
sales_at_delvens.com
www.delvens.com
3
Market Overview
Immunology is a discipline of medical and
biological research that studies the immune
system. The immune system defends us against
infection in a variety of ways. Diseases such as
autoimmunity, allergies, and cancer can occur
when the human immune system is not operating
properly. Autoimmune diseases occur when the
immune system attacks the body that its meant to
protect. People suffering from autoimmune
diseases have a defect that makes their immune
system unable to distinguish 'self' from
non-self or 'foreign' molecules. Immunology
provides a wide variety of laboratory tests for
the detection of autoimmune diseases. The growth
of the market can be attributed to various
factors such as the Increasing prevalence of
autoimmune disorders and increasing product
approvals by regulatory agencies.
sales_at_delvens.com
www.delvens.com
4
Market Overview
On the other hand, the high costs of immunology
drugs, adverse effects associated with these
drugs, and lack of awareness are the major
factors that can hinder the growth of the global
immunology market. The negative effect of the
global pandemic, COVID-19, has been felt across
several economies facing unprecedented loss, this
is owing to the lockdown announced by the
government agencies, due to which several
industries have been at a standstill with limited
operational activities. However, a collective
effort from the government and the industries is
likely to bring the economy back on track, and
aid in the resumption of industrial activities.
sales_at_delvens.com
www.delvens.com
5
Market Segmentation

• Immunology Market is segmented into various
  segments such as drug class, disease indication,
  distribution channel, and region
• Based on the distribution channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Based on region
• Asia Pacific
• North America
• Europe
• South America
• Middle East Africa

sales_at_delvens.com
www.delvens.com
6
Market Segmentation
On the basis of the drug class Monoclonal
Antibody (mAb) Fusion Proteins
Immunosuppressants Polyclonal Antibody
(pAb) Based on disease indication
Rheumatoid Arthritis Psoriatic Arthritis
Plaque Psoriasis Ankylosing Spondylitis
Inflammatory Bowel Disease Prophylaxis of
Organ Rejection
sales_at_delvens.com
www.delvens.com
7
Competitive Landscape
AbbVie Inc. Janssen Global Services Johnson
Johnson F. Hoffmann-La Roche Ltd Amgen
Inc. Novartis Astellas Merck Sharp Dohme
Corp.
Inquire Before Buying https//www.delvens.com/In
quire-before-buying/immunology-market-trends-forec
ast-till-2030
sales_at_delvens.com
www.delvens.com
8
Recent Developments

• August 29, 2022 - AbbVie Showcases New Analyses
  and Real-World Data Across Multiple
  Immune-Mediated Skin Diseases at the European
  Academy of Dermatology and Venereology (EADV).
• August 24, 2022 - AbbVie announced that the U.S.
  Food and Drug Administration (FDA) approved the
  use of IMBRUVICA (ibrutinib) for the treatment
  of pediatric patients one year and older with
  chronic graft versus host disease (cGVHD) after
  the failure of one or more lines of systemic
  therapy.

Purchase This Report https//www.delvens.com/che
ckout/immunology-market-trends-forecast-till-2030

sales_at_delvens.com
www.delvens.com
9
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-8638-5055 sales_at_del
vens.com WEBSITE https//delvens.com/
sales_at_delvens.com
www.delvens.com